Skip to main content

Significant discovery could tackle spread of breast cancer

• New discovery reveals testing for molecule αvβ6 could identify a subset of breast cancer patients at high risk of their tumours spreading from the breast - and therefore twice as likely to die within five years
• Combining αvβ6- antibody drug with breast cancer drug Herceptin ‘eradicated’ tumours in mice
• Researchers are now looking at options to progress to a clinical trial in breast cancer patients

Published on:

For media information, contact:

Back to top